82 FR 31780 - Sunshine Act Meeting: Advisory Council for the Elimination of Tuberculosis Meeting (ACET)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 130 (July 10, 2017)

[Federal Register Volume 82, Number 130 (Monday, July 10, 2017)]
[Notices]
[Page 31780]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-14516]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Sunshine Act Meeting: Advisory Council for the Elimination of 
Tuberculosis Meeting (ACET)

Time and Date: 10:00 a.m.-3:30 p.m., EDT, August 22, 2017

Place: Web conference. Toll free number 1-877-927-1433, Participant 
Code: 12016435, To join the meeting: https://adobeconnect.cdc.gov/r5p8l2tytpq/.

Status: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention announces the meeting of the ACET. This meeting is open to 
the public. The meeting room accommodates 100 ports. Persons who desire 
to make an oral statement, may request it at the time of the public 
comment period on August 22, 2017 at 3:20p.m. EDT. Public participation 
and ability to comment will be limited to space and time as it permits.

Matters to be Considered: This council advises and makes 
recommendations to the Secretary of Health and Human Services, the 
Assistant Secretary for Health, and the Director, CDC, regarding the 
elimination of tuberculosis (TB). Specifically, the Council makes 
recommendations regarding policies, strategies, objectives, and 
priorities; addresses the development and application of new 
technologies; and reviews the extent to which progress has been made 
toward eliminating tuberculosis. Agenda items include the following 
topics: (1) Update on making latent tuberculosis infection (LTBI) 
reportable from the Council of State and Territorial Epidemiologists 
(CSTE) meeting; (2) Update data on LTBI testing and treatment from 
Aggregate Reports for Tuberculosis Program Evaluation (ARPE); (3) 
Update on CDC's efforts to transition to whole-genome sequencing; (4) 
Updates from Workgroups; and (5) other tuberculosis-related issues. 
Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Margie Scott-Cseh, CDC, 1600 
Clifton Road NE., M/S E-07, Atlanta, Georgia 30333, telephone (404) 
639-8317; Email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 2017-14516 Filed 7-6-17; 4:15 pm]
 BILLING CODE 4163-18-P